BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

696 related articles for article (PubMed ID: 25164159)

  • 1. [Practical clinical aspects of oocyte vitrification for fertility preservation].
    Courbiere B; Decanter C
    Gynecol Obstet Fertil; 2014 Sep; 42(9):653-6. PubMed ID: 25164159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro maturation of human immature oocytes for fertility preservation.
    Chian RC; Uzelac PS; Nargund G
    Fertil Steril; 2013 Apr; 99(5):1173-81. PubMed ID: 23433515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Systematic proposal of fertility preservation by mature oocyte cryopreservation for recurrent benign ovarian tumors].
    Dadoun Y; Azaïs H; Keller L; d'Orazio E; Collinet P; Decanter C
    Gynecol Obstet Fertil Senol; 2017 Jun; 45(6):359-365. PubMed ID: 28506797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Random Start Ovarian Stimulation for Oocyte or Embryo Cryopreservation in Women Desiring Fertility Preservation Prior to Gonadotoxic Cancer Therapy.
    Danis RB; Pereira N; Elias RT
    Curr Pharm Biotechnol; 2017 Nov; 18(8):609-613. PubMed ID: 28786354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Fertility preservation in breast cancer patients: the state of art in 2014?].
    Comtet M; Sonigo C; Valdelièvre C; Sermondade N; Sifer C; Grynberg M
    Bull Cancer; 2015 May; 102(5):443-53. PubMed ID: 25739327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ovarian response to controlled ovarian hyperstimulation in cancer patients is diminished even before oncological treatment.
    Domingo J; Guillén V; Ayllón Y; Martínez M; Muñoz E; Pellicer A; Garcia-Velasco JA
    Fertil Steril; 2012 Apr; 97(4):930-4. PubMed ID: 22283969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Five years' experience using oocyte vitrification to preserve fertility for medical and nonmedical indications.
    Garcia-Velasco JA; Domingo J; Cobo A; Martínez M; Carmona L; Pellicer A
    Fertil Steril; 2013 Jun; 99(7):1994-9. PubMed ID: 23465707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fertility preservation using controlled ovarian hyperstimulation and oocyte cryopreservation in a premenarcheal female with myelodysplastic syndrome.
    Reichman DE; Davis OK; Zaninovic N; Rosenwaks Z; Goldschlag DE
    Fertil Steril; 2012 Nov; 98(5):1225-8. PubMed ID: 22884018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oocyte vitrification versus ovarian cortex transplantation in fertility preservation for adult women undergoing gonadotoxic treatments: a prospective cohort study.
    Diaz-Garcia C; Domingo J; Garcia-Velasco JA; Herraiz S; Mirabet V; Iniesta I; Cobo A; Remohí J; Pellicer A
    Fertil Steril; 2018 Mar; 109(3):478-485.e2. PubMed ID: 29428307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [In vitro oocyte maturation for female fertility preservation].
    Sonigo C; Grynberg M
    Gynecol Obstet Fertil; 2014 Sep; 42(9):657-60. PubMed ID: 25153445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Live birth using vitrified--warmed oocytes in invasive ovarian cancer: case report and literature review.
    Alvarez M; Solé M; Devesa M; Fábregas R; Boada M; Tur R; Coroleu B; Veiga A; Barri PN
    Reprod Biomed Online; 2014 Jun; 28(6):663-8. PubMed ID: 24745835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fertility after breast cancer treatment.
    Kasum M; Beketić-Orešković L; Peddi PF; Orešković S; Johnson RH
    Eur J Obstet Gynecol Reprod Biol; 2014 Feb; 173():13-8. PubMed ID: 24315568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Oncofertility and breast cancer].
    Sonigo C; Grynberg M; Bringer S; Sermondade N
    Bull Cancer; 2019 Dec; 106(12S1):S43-S52. PubMed ID: 32008738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Is there any place for oocyte cryopreservation after cancer treatment?].
    Decanter C
    Gynecol Obstet Fertil; 2013 Sep; 41(9):515-7. PubMed ID: 23988474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is vitrification of oocytes useful for fertility preservation for age-related fertility decline and in cancer patients?
    Cobo A; Garcia-Velasco JA; Domingo J; Remohí J; Pellicer A
    Fertil Steril; 2013 May; 99(6):1485-95. PubMed ID: 23541405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Fertility preservation in oncology].
    Chaput L; Grémeau AS; Vorilhon S; Pons H; Chabrot C; Grèze V; Pouly JL; Brugnon F
    Bull Cancer; 2018 Jan; 105(1):99-110. PubMed ID: 29221621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ovarian reserve and response to stimulation in women undergoing fertility preservation according to malignancy type.
    Lefebvre T; Mirallié S; Leperlier F; Reignier A; Barrière P; Fréour T
    Reprod Biomed Online; 2018 Aug; 37(2):201-207. PubMed ID: 29784618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indications for fertility preservation in women from malignant diseases to benign conditions to age-related fertility decline.
    Dolmans MM; Donnez J
    Minerva Ginecol; 2018 Aug; 70(4):402-407. PubMed ID: 29644332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fertility preservation for age-related fertility decline.
    Stoop D; Cobo A; Silber S
    Lancet; 2014 Oct; 384(9950):1311-9. PubMed ID: 25283572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Fertility preservation techniques in women of reproductive age ].
    Vulliemoz N ; Gaitzsch H ; Primi M-P ; Wunder D ; Perey L ; Streuli I
    Rev Med Suisse; 2014 Oct; 10(447):1961-2, 1964-6, 1968. PubMed ID: 25518205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.